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(Walworth et al., 1993; Walworth and Bernards, 1996).
The genes rad24 and rad25 (Ford et al., 1994) encode
14-3-3 proteins, a class of small acidic proteins that
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bind to signaling molecules including phosphatases. SoLondon WC2A 3PX
do these components interact with the core cell cycleUnited Kingdom
regulators to bring about a block over mitosis? A hint
that Cdc2 might be the ultimate target of such check-
point controls came from the observation that certain
Occasionally, a field of study gets to a stage when sev- fission yeast mutants that alter the Y15 phosphorylation
eral different strands of enquiry start coming together state of Cdc2 could undergo mitosis when S phase was
and real advances seem to be just over the horizon. blocked (Enoch et al., 1991). The uncoupling of mitosis
This appears to be the case for the cell cycle checkpoint from S phase was observed in a Cdc2 Y15F mutant or
control that prevents mitosis when DNA is damaged and in cells overproducing the Cdc25 tyrosine phosphatase.
is not yet repaired. Recent work, mainly with fission It was initially thought that the fission yeast DNA damage
yeast and mammalian cells, is revealing how this check- checkpoint control might not act through Cdc2 Y15
point signaling pathway interacts with cell cycle regula- phosphorylation (Barbet and Carr, 1993), but more re-
tors to block the onset of mitosis, and suggests that cent work has indicated that this is likely to be the case.
there may be a common molecular mechanism underly- Mutant cells with reduced Y15 phosphorylation are un-
ing this control in a wide range of living organisms. able to sustain a block over mitosis in response to DNA
Checkpoint Controls damage (Rhind et al., 1997), and Y15 phosphorylation
Progression through the cell cycle is controlled by core is maintained in wild-type cells for the duration of the
cell cycle regulators, the most prominent of which are mitotic delay imposed by irradiation (O'Connell et al.,
the cyclin-dependent kinases (CDKs). Sequential activa- 1997; Rhind et al., 1997). Similar conclusions have been
tion of different CDKs are responsible for controlling the reached from experiments in Aspergillus (Yeet al., 1997).
onset of S phase and mitosis, and for ensuring that there Genetic interactions in fission yeast suggested a link
between Cdc2 and Chk1 (Walworth et al., 1993), al-is only one S phase per cell cycle. Onset of mitosis is
though curiously, they implied that Chk1 might be anbrought about by the CDK Cdc2, regulated in part by
activator of Cdc2 rather than an inhibitor. More recentlythe inhibitory Wee1 protein kinases and the activatory
coimmunoprecipitation experiments have shown thatCdc25protein phosphatases. These enzymes determine
Chk1 is physically associated with Cdc25 in vivo (Furnarithe Y15 phosphorylation state of Cdc2, which only
et al., 1997). These experiments lead to a model in whichachieves full protein kinase activity when Y15 is dephos-
Chk1 is modified in a Rad3-dependent manner afterphorylated. If the cell cycle is perturbed by a block of
DNA damage and stops Cdc2 activation by inhibitingDNA replication or by unrepaired DNA damage, then
Cdc25 (Figure 1). In this way, onset of mitosis is blockedmitosis is prevented until the perturbation is corrected.
until the DNA is repaired.This mechanism contributes to the fidelity of genomic
DNA Damage Checkpoint in Mammalian Cellstransmission at cell division. The first insight into this
The story now moves tomammalian cells. A human Chk1cell cycle control was provided by a perceptive study
homolog isolated by PCR has 29% protein sequencein the budding yeast that identified checkpoint mutants
identity to fission yeast Chk1 (Sanchez et al., 1997).able to undergo mitosis even if DNA damage was unre-
Baculovirus-produced human Chk1 binds and phos-paired (Hartwell and Weinert, 1989). This work led to the
phorylates three Cdc25 homologs in vitro, includingproposal that the replication and damage status of DNA
Cdc25C, which regulates Cdc2 at the onset of mitosis.is monitored or ªchecked,º and that this information is
The relevant phosphorylation site onCdc25C was mapped
communicated by a regulatory pathway to mitotic cell
to S216, a residue embedded in a potential recognition
cycle regulators leading to a block over mitosis. The
motif for the binding of 14-3-3 proteins. The same
checkpoint mutants were thought to define components Cdc25C S216 residue is phosphorylated in vivo in HeLa
involved in monitoring the status of DNA or in communi- and Jurkat cells, and this phosphorylation is observed
cating this information to the mitotic regulators. Subse- throughout the cell cycle except at mitosis (Peng et
quently, checkpoint mutants were identified in fission al., 1997). There are at least seven isoforms of 14-3-3
yeast and mammalian cells, suggesting that similar con- proteins in mammalian cells, and antibodies that recog-
trols existed in other organisms. nize several of these isoforms were used to demonstrate
DNA Damage Checkpoint in Fission Yeast that Cdc25C immunoprecipitates from cell extracts con-
In fission yeast, many genes have been identified in this tain 14-3-3 proteins. A Cdc25C S216A protein expressed
checkpoint regulatory pathway (Weinert, 1997), includ- in HeLa cells failed to bind any 14-3-3 proteins, estab-
ing rad3, chk1, and rad24/25, all of which are relevant lishing that S216 phosphorylation is essential for the
to the present advance in understanding. rad3 has se- binding. Furthermore, binding to wild-type Cdc25C is
quence similarity with ATM, a gene mutated in patients detected throughout the cell cycle except at mitosis
with ataxia telangiectasia, and has been shown to act (Peng et al., 1997). If these mammalian and fission yeast
upstream of the Chk1 protein kinase. The Chk1 kinase results are now combined, then a very attractive model
becomes phosphorylated in response to DNA damage emerges (Figure 1). After DNA damage, a signal is com-
municated to Chk1, perhaps via an ATM protein (Rad3).during G2, and when overproduced causes mitotic delay
Cell
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Figure 1. Speculative Model of How Signals
Generated by the DNA Damage Checkpoint
Controls Are Communicated to Cell Cycle
Regulators
Based on results from fission yeast and mam-
malian cells. See text for detailed expla-
nation.
Chk1 then phosphorylates Cdc25 on S216, and this protein kinase. These data suggest that in epithelial
cells, 14-3-3s is induced in a p53-dependent manner inphosphorylation potentiates 14-3-3 (Rad24/25) binding
to Cdc25. This binding prevents Cdc25 from dephos- response to irradiation and contributes to the G2 block
induced by irradiation. Binding of 14-3-3 does not inhibitphorylating Cdc2 Y15, and as a consequence, the onset
of mitosis is blocked. Cdc25 S216 is phosphorylated Cdc25C phosphatase activity (Peng et al., 1997), but
because ectopically produced 14-3-3s is found in thethrough much of the cell cycle even in cells with undam-
aged DNA, suggesting that DNA damage±induced acti- cytoplasm, binding may act by preventing entry of
Cdc25C into the nucleus, thus preventing the activationvation of Chk1 acts to maintain S216 phosphorylation
in cells that have reached the end of G2 and that would of Cdc2.
Validating the Modelotherwise undergo mitosis.
After irradiation of HeLacells, Chk1 undergoes a small Much of the data outlined above indicates what might
happen duringoperation of the DNA damage checkpointmobility shift (Sanchez et al., 1997) like Chk1 in fission
yeast, although unlike fission yeast, overproduction of control but does not yet fully establish what in fact does
happen. It is now necessary to monitor the Chk1, 14-3-3,Chk1 in HeLa cells does not block mitosis. If Cdc25C
S216A is produced in HeLa cells arrested in S phase, Cdc25C, and Cdc2 proteins in various mammalian cell
types and to demonstrate that during the G2 delay in-then 3.8% of the cells enter mitosis. More strikingly, if
cells expressing Cdc25C S216A are irradiated, within duced by irradiation, Cdc25C is phosphorylated by Chk1
and as a consequence, 14-3-3 proteins form complexes24 hr, 60% of the cells undergo mitosis compared with
only 9% of cells in a wild-type control (Peng et al., 1997). with Cdc25C, preventing Cdc2 activation. Mutants in
these genes should be constructed to test their effectsThis experiment indicates that thepresence of a Cdc25C
tyrosine phosphatase that cannot bind 14-3-3 proteins on the checkpoint control, and efforts should be made
to ensure that the 14-3-3 isoforms and Chk1 proteinscompromises the DNA damage checkpoint control. The
idea that the checkpoint inhibits the Cdc25C tyrosine that act in the control have been correctly identified.
Finally, it is necessary to establish if ATM definitely hasphosphatase is also consistent with the observed ef-
fects of irradiation on Cdc2 Y15 phosphorylation (Khar- a role in activating the pathway in response to DNA
damage. Further work is also required in fission yeast.banda et al., 1994).
Further support for such a model being operational The changes in the Rad3, Rad24/25, 14-3-3 proteins,
and Cdc25 should be monitored after DNA damage, andin mammalian cells comes from a paper in theDecember
issue of Molecular Cell (Hermeking et al., 1997). Human the role of Wee1 should be clarified.Chk1 can phosphor-
ylate Wee1 in vitro, and overproduction of Chk1 in cellscolorectal carcinoma cells up-regulate the gene encod-
ing the 14-3-3s or stratifin protein in response to irradia- lacking Wee1 does not cause any mitotic delay until
several generations have elapsed (O'Connell et al.,1997;tion. 14-3-3s expression is found in epithelial cells but
not in fibroblasts or endothelial cells. The majority of Rhind et al., 1997), unlike wild-type cells, which respond
almost immediately. These results suggest that Wee1human cancers arise from epithelial cells, and the p53
tumor suppressor gene is genetically inactivated in may also have a role in Chk1-mediated inhibition of
Cdc2. In budding yeast, the DNA damage checkpointmany of these cancers. The 14-3-3s gene contains p53
binding sites in its upstreamregulatory regions, isupreg- does not operate through Y15 phosphorylation (Weinert,
1997) and so other mechanisms must be operative thatulated when p53 is overexpressed, and is not induced
after irradiation when p53 is absent from cells. When may contribute to the checkpoint control in other or-
ganisms.14-3-3s is overexpressed, cells arrest in G2 prior to
mitosis, and cells lacking p21 proceed to undergo fur- Relevance for Cancer
This model for the DNA damage checkpoint control alsother rounds of DNA replication. Both of these phenom-
ena are explicable by 14-3-3s inhibition of the Cdc2 has implications for cancer. It is of interest that chk1
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has been mapped to 11q24 (Sanchez et al., 1997), a
region that has been associated with a number of can-
cers. Alterations to p53 occurring during cancer pro-
gression abrogate the DNA damage checkpoint control,
allowing nuclei with damaged or altered genomes to
undergo mitosis, producing cells that eventually un-
dergo apoptosis (Hermeking et al., 1997). These differ-
ences between normal and cancer cells could account
for the usefulness of radiotherapy and some types of
chemotherapy for treating cancer. Modulating the be-
havior of components in the checkpoint pathway such
as Chk1, 14-3-3, or Cdc25 could improve such therapies.
For example, weakening the checkpoint control further
in cancer cells or strengthening it in normal cells could
be beneficial for the differential killing of cancer cells
after radiotherapy. The likely conservation of these
checkpoint controls means that fission yeast is a conve-
nient model system both for the further characterization
of the checkpoint pathway and for the development of
relevant assays and screening procedures. These will
be helpful to identify drugs and other therapeutic agents
modulating the checkpoint control that could improve
the treatment of cancer.
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